Psychiatric adverse events
1 paper
- Humans1
Latest
3 in 12 monthsFrontiers in Pharmacology
Indication-specific adverse event profiles of semaglutide and liraglutide: a FAERS disproportionality analysis
Cross-sectional study of 33,259 peopleLiraglutide
Diabetes, Obesity & Metabolism
Psychiatric Safety of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Adolescents With Obesity
Cohort study of 9,222 peopleGLP-1 receptor agonists
Frontiers in Pharmacology
Reporting patterns of suicide- and self-injury-related events involving liraglutide, semaglutide, and tirzepatide: data from the European pharmacovigilance database
Cohort study of 42,941 peoplePopulations
ENDO 2025 Abstract
SUN-665 Meta-Analysis of Psychiatric and Quality of Life Outcomes in Patients With Obesity and Diabetes Treated With Glucagon-Like Peptide 1 Receptor Agonists
Meta-analysis of randomised trialsGLP-1 receptor agonists